Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
NCT06254235
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
The test octreotide microsphere
DRUG:
The reference octreotide microsphere
Sponsor
Qilu Pharmaceutical Co., Ltd.